Zevra Therapeutics, Inc. ZVRA Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s total current liabilities?
- Zevra Therapeutics, Inc. (ZVRA) reported total current liabilities of $47.03M in Q1 2026.
- How has Zevra Therapeutics, Inc.'s total current liabilities changed year-over-year?
- Zevra Therapeutics, Inc.'s total current liabilities increased by 74.3% year-over-year, from $26.98M to $47.03M.
- What is the long-term trend for Zevra Therapeutics, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s total current liabilities has grown at a 39.1% compound annual growth rate (CAGR), from $7.54M to $39.28M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.